Cargando…

Remdesivir retreatment: another unproven intervention for COVID-19

Detalles Bibliográficos
Autores principales:	Al-Heeti, Omar, Kumar, Rebecca N., Kling, Kendall, Angarone, Michael, Achenbach, Chad, Taiwo, Babafemi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865007/ https://www.ncbi.nlm.nih.gov/pubmed/35022726 http://dx.doi.org/10.1093/jac/dkab472

Ejemplares similares

Association of statin use with outcomes of patients admitted with COVID-19: an analysis of electronic health records using superlearner
por: Rivera, Adovich S., et al.
Publicado: (2023)

Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven
por: Shih, Richard D., et al.
Publicado: (2020)

Benefits of nirmatrelvir–ritonavir remain unproven for some populations
por: McDonald, Emily G., et al.
Publicado: (2022)

Financial risks posed by unproven cell interventions: Estimation of refunds from medical expense deductions in Japan
por: Hatta, Taichi, et al.
Publicado: (2022)

A cluster of six respiratory cultures positive for Mycobacterium xenopi –Clinical characteristics and genomic characterization
por: Kling, Kendall, et al.
Publicado: (2023)

Unproven Therapies for Diabetes and Their Implications
por: Kesavadev, Jothydev, et al.
Publicado: (2016)

Unproven Therapy Algorithms for Early SARS-CoV-2 Infection Are Dangerous
por: Olmos, Rodrigo Diaz, et al.
Publicado: (2021)

Phosphoethanolamine and the danger of unproven drugs
por: Pondé, Noam, et al.
Publicado: (2016)

Designing persuasive health education for patients seeking unproven stem cell interventions
por: Kawam, Omar, et al.
Publicado: (2023)

Vitamin D supplementation and COVID-19 disease: safety but unproven efficacy—reply to Dr Helga Rhein
por: Harvey, Nicholas C., et al.
Publicado: (2021)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

The involvement of Canadian physicians in promoting and providing unproven and unapproved stem cell interventions
por: Ogbogu, Ubaka, et al.
Publicado: (2018)

Threat posed by unproven drugs in medical oncology
por: Pondé, Noam, et al.
Publicado: (2016)

Unproven stem cell therapy for macular degeneration
por: Ansari, Zubair A., et al.
Publicado: (2017)

Patients' Attitudes to Unproven Therapies in Treating COVID-19 Merit Evaluation
por: Li, Hong-tian, et al.
Publicado: (2020)

Patients' Attitudes to Unproven Therapies in Treating COVID-19 Merit Evaluation
por: Li, Hong-tian, et al.
Publicado: (2020)

No difference in anti-spike antibody and surrogate viral neutralization following SARS-CoV-2 booster vaccination in persons with HIV compared to controls (CO-HIV Study)
por: Kling, Kendall D., et al.
Publicado: (2023)

Real-World Experience of Bamlanivimab for Coronavirus Disease 2019 (COVID-19): A Case-Control Study
por: Kumar, Rebecca N, et al.
Publicado: (2021)

Regulatory and policy tools to address unproven stem cell interventions in Canada: the need for action
por: Caulfield, Timothy, et al.
Publicado: (2019)

Diesel engine exhaust and lung cancer: an unproven association.
por: Muscat, J E, et al.
Publicado: (1995)

Our favorite unproven ideas for future critical care
por: Marini, John J, et al.
Publicado: (2013)

Endometrial Receptivity Analysis (ERA) test: an unproven technology
por: Ben Rafael, Zion
Publicado: (2021)

Mycobacterium arupense as an Emerging Cause of Tenosynovitis
por: Lopez, Fiorella Krapp, et al.
Publicado: (2016)

Unproven stem cell–based interventions and achieving a compromise policy among the multiple stakeholders
por: Matthews, Kirstin R. W., et al.
Publicado: (2015)

HEALTH EFFECTS OF SIT-STAND DESKS AND INTERVENTIONS AIMED TO REDUCE SITTING AT WORK ARE STILL UNPROVEN
Publicado: (2016)

HEALTH EFFECTS OF SIT-STAND DESKS AND INTERVENTIONS AIMED TO REDUCE SITTING AT WORK ARE STILL UNPROVEN
Publicado: (2016)

Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions
por: Horner, Claire, et al.
Publicado: (2018)

Unproven stem cell interventions: A global public health problem requiring global deliberation
por: Master, Zubin, et al.
Publicado: (2021)

Unproven cell interventions in Poland and the exploitation of European Union law on advanced therapy medicinal products
por: Dulak, Józef, et al.
Publicado: (2023)

Remdesivir in Breastfeeding
por: Sadati, Elham, et al.
Publicado: (2022)

Retreatments must be included in the evaluation of device performance
por: Chapot, René, et al.
Publicado: (2021)

Indian perspective of remdesivir: A promising COVID-19 drug
por: Singh, Devendra, et al.
Publicado: (2020)

Dangerous medicines: Unproven AIDS cures and counterfeit antiretroviral drugs
por: Amon, Joseph J
Publicado: (2008)

Unproven medical devices and cancer therapy: big claims but no evidence
por: Mac Manus, MP
Publicado: (2008)

Thinking forward: promising but unproven ideas for future intensive care
por: Marini, John J., et al.
Publicado: (2019)

Scientific Papers and Patents on Substances with Unproven Effects. Part 2
por: Jargin, Sergei V.
Publicado: (2019)

Disseminated melioidosis in early pregnancy - an unproven cause of foetal loss
por: Chang, Chee Yik, et al.
Publicado: (2020)

Pulmonary administration of remdesivir in the treatment of COVID-19
por: Rasmussen, Henrik Berg, et al.
Publicado: (2020)

Remdesivir for COVID-19: Why Not Dose Higher?
por: Yan, Victoria C., et al.
Publicado: (2021)

Remdesivir for the treatment of COVID-19: author's response
por: Lee, Todd C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rcc80ia12k81i58262ftosb8le